Roles of an endogenous peptide ELABELA in ameliorating hyperuricemia by inhibiting uric acid production via CYP27A1-modulated bile acid metabolism in mice
- 9 October 2025
- journal article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 242 (Pt 4) , 117408
Abstract
No abstract availableKeywords
Funding Information
- Guangdong Provincial Medical Research Foundation (B2025240)
This publication has 30 references indexed in Scilit:
- Polysaccharide extracted from Phellinus igniarius attenuated hyperuricemia by modulating bile acid metabolism and inhibiting uric acid synthesis in adenine/potassium oxonate-treated miceJournal of Ethnopharmacology, 2025
- In vivo mouse models to study bile acid synthesis and signalingHepatobiliary & Pancreatic Diseases International, 2023
- The role of Elabela in kidney diseaseInternational Urology and Nephrology, 2021
- Bile Acid Homeostasis in a Cholesterol 7α‐Hydroxylase and Sterol 27‐Hydroxylase Double Knockout Mouse ModelHepatology, 2019
- Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–2016Arthritis & Rheumatology, 2019
- Taurine decreased uric acid levels in hyperuricemic rats and alleviated kidney injuryBiochemical and Biophysical Research Communications, 2017
- Regulation of uric acid metabolism and excretionInternational Journal of Cardiology, 2016
- ELABELA: A Hormone Essential for Heart Development Signals via the Apelin ReceptorDevelopmental Cell, 2013
- Bile Acid Metabolism and SignalingComprehensive Physiology, 2013
- Prevalence of gout and hyperuricemia in the US general population: The National Health and Nutrition Examination Survey 2007-2008Arthritis & Rheumatism, 2011